BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 1692727)

  • 1. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
    Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.
    Hashida S; Hashinaka K; Ishikawa S; Ishikawa E
    J Clin Lab Anal; 1997; 11(5):267-86. PubMed ID: 9292394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays.
    Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Ishikawa E
    Clin Diagn Lab Immunol; 2000 Nov; 7(6):872-81. PubMed ID: 11063490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.
    Jiang JD; Chu FN; Naylor PH; Kirkley JE; Mandeli J; Wallace JI; Sarin PS; Goldstein AL; Holland JF; Bekesi JG
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):382-90. PubMed ID: 1372353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal conditions of immune complex transfer enzyme immunoassays for antibody IgGs to HIV-1 using recombinant p17, p24, and reverse transcriptase as antigens.
    Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Shimada K; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Lab Anal; 1998; 12(2):98-107. PubMed ID: 9524294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping of the HIV-1 gag region by analysis of gag gene deletion fragments expressed in Escherichia coli defines eight antigenic determinants.
    Marcus-Sekura CJ; Woerner AM; Zhang PF; Klutch M
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):317-27. PubMed ID: 1692722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
    Shang F; Huang H; Revesz K; Chen HC; Herz R; Pinter A
    J Virol; 1991 Sep; 65(9):4798-804. PubMed ID: 1714518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
    Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominant epitopes of HIV-1 p17 and p24.
    Graham S; Follett EA; Wallace L; Desselberger U; Marsden HS
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1781-8. PubMed ID: 1280955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complex transfer enzyme immunoassay for antibody IgM to HIV-1 p17 antigen.
    Hashida S; Ishikawa S; Nishikata I; Hashinaka K; Oka S; Ishikawa E
    J Clin Lab Anal; 1998; 12(6):329-36. PubMed ID: 9850183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antibodies reacting with HIV gag proteins occasionally found in the serum of non-infected subjects.
    Bürgisser P; Frei PC
    Clin Exp Immunol; 1991 Aug; 85(2):219-23. PubMed ID: 1713811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
    Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
    Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
    Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J
    AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive enzyme immunoassay of antibodies to HIV-1 p17 antigen using indirectly immobilized recombinant p17 for diagnosis of HIV-1 infection.
    Ishikawa S; Hashinaka K; Hashida S; Oka S; Ishikawa E
    J Clin Lab Anal; 1998; 12(6):343-50. PubMed ID: 9850185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.
    Chargelegue D; O'Toole CM; Colvin BT
    Clin Exp Immunol; 1993 Sep; 93(3):331-6. PubMed ID: 8370162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.